Management of erosive lichen planus with topical tacrolimus and recurrence secondary to metoprolol

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 2, 2005, Pages 236-239

  Meyer, S ^a   Burgdorff, T ^a   Szeimies, R M ^a   Vogt, T ^a   Landthaler, M ^a   Karrer, Sigrid ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

receptor blockers; Cutaneous side effects; Erosive lichen planus; FK506; Tacrolimus

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; METHOTREXATE; METOPROLOL; PSORALEN; RETINOID; TACROLIMUS;

ACANTHOSIS; ACRODERMATITIS; AGED; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FINGER NAIL; FOOT DISEASE; HAND DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERKERATOSIS; INFLAMMATORY INFILTRATE; LICHEN PLANUS; MALE; MOUTH ULCER; MUSCLE HYPERTONIA; NAIL DISEASE; PAIN; PERIPHERAL EDEMA; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PTERYGIUM; PUSTULE; RECURRENT DISEASE; REMISSION; SKIN BURNING SENSATION; SKIN DEFECT; TREATMENT PLANNING; ULTRAVIOLET A RADIATION;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; AGED; FOOT DERMATOSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS; MALE; METOPROLOL; TACROLIMUS;

EID: 16244390279     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.01116.x     Document Type: Article

References (19)

1. Rebora A. Erosive lichen planus: What is this? Dermatology 2002; 205: 226-228.
2. Oberste-Lehn H, Kühl M. Lichen planus pemphigoides mit Ulcerationen und Anonychie. Z Haut Geschlechtskr 1954; 17: 195-199.
3. Shiohara T, Moriya BS, Nagashima M. The lichenoid tissue reaction, a new concept of pathogenesis. Int J Dermatol 1988; 27 365-374.
4. Thompson DF, Skaehill PA. Drug-induced lichen planus. Pharmacotherapy 1994; 14: 561-571.
5. Hödl Z. Cutaneous side effects of beta blocking agents. Z Hautkr 1983; 58: 17-28.
6. Massa C, Jason SM, Gradini R, Welykyj S. Lichenoid drug eruption secondary to propranolol. Cutis 1991; 48: 41-43.
7. Gange RW, Jones EW. Bullous lichen planus caused by labetalol. Br Med J 1978; 1: 816-817.
8. Lener EV, Brieva J, Schachter M et al. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 2001; 137: 419-432.
9. Cribier B, Frances C, Chosidow O. Treatment of lichen planus: an evidence-based medicine analysis of efficacy. Arch Dermatol 1998; 134: 1521-1530.
10. Lehtinen R, Happonen RP, Kuusilehto, A, Jansen C. A clinical trial of PUVA treatment in oral lichen planus. Proc Finn Dent Soc 1989; 85: 29-33.
11. Lundquist G, Forsgren H, Gajecki M, Emstetam L. Photochemotherapy of oral lichen planus: a controlled study. Oral Surg Oral Med Oral Radiol Endod 1995; 79: 554-558.
12. Ruzicka T, Assmann T, Homey B. Tacrolimus: the drug for the turn of the millennium? Arch Dermatol 1999; 135: 574-580.
13. Bieber T. Topical tacrolimus (FK506): a new milestone in the management of atopic dermatitis. J Allergy Clin Immunol 1998; 102: 555-557.
14. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128-137.
15. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 2001; 44: 595-598.
16. Katoh N, Mihara H, Yasuno H. Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 2002; 147: 154-156.
17. Yamamoto P, Nishioka K. Topical tacrolimus is effective for facial treatment of psoriasis. Acta Derm Venereol 2000; 80: 451.
18. Olivier V, Lacour JP, Mousnier A et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus. Arch Dermatol 2002; 138: 1335-1338.
19. Kaliakatsou F, Hodgson TA, Lewsey JD et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002; 46: 35-41.